GlassScriptPhysician profile
Ann M Waldron
NPI 1184229429
$6,242.57
in general payments reported to CMS, 2019-2025
34 companies · $1,228 in 2025
The $1,228 reported for 2025 was more than what 88% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $284 · 2022: $1,136 · 2023: $1,470 · 2024: $2,124 · 2025: $1,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,822.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $846.48 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $585.07 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $458.89 | 2021-2025 | Mounjaro, Zepbound, Kisunla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $380.75 | 2021-2025 | Xifaxan |
| Abbvie INC. | $379.49 | 2023-2025 | |
| Pfizer INC. | $359.62 | 2021-2025 | |
| Gilead Sciences, INC. | $332.98 | 2023-2024 | Epclusa, Livdelzi |
| Exact Sciences Corporation | $305.63 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amgen INC. | $300.35 | 2023-2025 | Evenity, Repatha, Otezla |
| Dexcom, INC. | $261.63 | 2023-2025 | Dexcom G6 Transmitter |
| Horizon Therapeutics Plc | $227.55 | 2022-2023 | Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $225.83 | 2022-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $174.89 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $168.98 | 2023-2024 | Onpattro |
| Phathom Pharmaceuticals, INC. | $128.70 | 2024 | Voquezna |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $125.15 | 2024 | |
| Antares Pharma, INC. | $114.84 | 2023 | Xyosted, Tlando, Nocdurna |
| Madrigal Pharmaceuticals | $112.62 | 2025 | Rezdiffra |
| Dynavax Technologies Corporation | $97.03 | 2023-2024 | Heplisav-B |
| Ultragenyx Pharmaceutical INC. | $89.64 | 2022 | |
| Nestle Healthcare Nutrition INC. | $83.50 | 2022 | |
| Phadia US INC. | $66.95 | 2021 | |
| Azurity Pharmaceuticals, INC. | $65.08 | 2023 | Horizant |
| Genentech USA, INC. | $58.45 | 2021 | |
| Sumitomo Pharma America, INC. | $47.69 | 2023-2025 | Gemtesa |
| E.R. Squibb & Sons, L.L.C. | $45.32 | 2022-2025 | Camzyos |
| Glaxosmithkline, LLC. | $34.40 | 2022-2024 | Arexvy, Shingrix |
| Otsuka America Pharmaceutical, INC. | $33.45 | 2023-2024 | Rexulti, Nuedexta |
| Janssen Pharmaceuticals, INC | $30.90 | 2022 | |
| Baxter Healthcare | $26.22 | 2025 | Hillrom - Retinavue 700 Imager |
| Edwards Lifesciences Corporation | $23.37 | 2025 | Sapien 3 Ultra Resilia |
| Amarin Pharma, INC. | $21.58 | 2022 | |
| Merck Sharp & Dohme LLC | $15.62 | 2022 | |
| Xeris Pharmaceuticals, INC. | $13.92 | 2025 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Waldron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.